Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Ovary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05942300
What this trial is testing

CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Lan Coffman 30
Not applicableEnded earlyNCT00968799
What this trial is testing

Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study

Who this might be right for
Epithelial Ovarian CancerFallopian Tube Carcinoma
Cantonal Hospital of St. Gallen 6
Testing effectiveness (Phase 2)Study completedNCT01696032
What this trial is testing

SGI-110 in Combination With Carboplatin in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Astex Pharmaceuticals, Inc. 120
Early research (Phase 1)Looking for participantsNCT06930755
What this trial is testing

Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Nerviano Medical Sciences 24
Testing effectiveness (Phase 2)Study completedNCT00217555
What this trial is testing

Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00408655
What this trial is testing

Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerRecurrent Endometrial Carcinoma+9 more
National Cancer Institute (NCI) 38
Early research (Phase 1)Looking for participantsNCT06366490
What this trial is testing

Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerRecurrent Epithelial Ovarian Cancer Which Includes Epithelial Ovarian, Fallopian Tube and/or Primary Peritoneal Cancer
PhotonPharma, Inc. 8
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Early research (Phase 1)Ended earlyNCT00003380
What this trial is testing

Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00002903
What this trial is testing

Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTesticular Germ Cell Tumor
European Organisation for Research and Treatment of Cancer - EORTC 25
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Not applicableUnknownNCT06515678
What this trial is testing

Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

Who this might be right for
Ovarian CancerAntiangiogenic-Associated HypertensionAdjuvant Bevacizumab+1 more
Groupe Hospitalier Pitie-Salpetriere 9,464
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715216
What this trial is testing

EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 23
Large-scale testing (Phase 3)UnknownNCT01802749
What this trial is testing

Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
National Cancer Institute, Naples 406
Testing effectiveness (Phase 2)Study completedNCT01690598
What this trial is testing

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Who this might be right for
Ovarian Cancer
Vejle Hospital 22
Testing effectiveness (Phase 2)Study completedNCT01485848
What this trial is testing

EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer Recurrent
Esperance Pharmaceuticals Inc 49
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT02873962
What this trial is testing

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

Who this might be right for
Peritoneal CancerOvarian CancerFallopian Tube Cancer
Dana-Farber Cancer Institute 72
Testing effectiveness (Phase 2)Study completedNCT02736305
What this trial is testing

Use of Regorafenib in Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
National Cancer Centre, Singapore 21
Testing effectiveness (Phase 2)UnknownNCT00005025
What this trial is testing

Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
John Stoddard Cancer Center at Iowa Methodist Medical Center
Next Page